- Home
- MODV vs COCP Comparison
MODV vs COCP Comparison
Compare MODV & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- COCP
- Stock Information
- Founded
- MODV 1996
- COCP 2006
- Country
- MODV United States
- COCP United States
- Employees
- MODV N/A
- COCP 11
- Industry
- MODV Transportation Services
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- MODV Consumer Discretionary
- COCP Health Care
- Exchange
- MODV Nasdaq
- COCP Nasdaq
- Market Cap
- MODV 16.1M
- COCP 15.4M
- IPO Year
- MODV N/A
- COCP N/A
- Fundamental
- Price
- MODV $1.17
- COCP $1.52
- Analyst Decision
- MODV Buy
- COCP Strong Buy
- Analyst Count
- MODV 4
- COCP 1
- Target Price
- MODV $8.38
- COCP $7.00
- AVG Volume (30 Days)
- MODV 505.6K
- COCP 12.6K
- Earning Date
- MODV 05-08-2025
- COCP 05-20-2025
- Dividend Yield
- MODV N/A
- COCP N/A
- EPS Growth
- MODV N/A
- COCP N/A
- EPS
- MODV N/A
- COCP N/A
- Revenue
- MODV $2,753,789,000.00
- COCP N/A
- Revenue This Year
- MODV N/A
- COCP N/A
- Revenue Next Year
- MODV $5.64
- COCP N/A
- P/E Ratio
- MODV N/A
- COCP N/A
- Revenue Growth
- MODV N/A
- COCP N/A
- 52 Week Low
- MODV $0.96
- COCP $1.12
- 52 Week High
- MODV $32.82
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- MODV 39.11
- COCP 51.20
- Support Level
- MODV $1.28
- COCP $1.36
- Resistance Level
- MODV $1.54
- COCP $1.74
- Average True Range (ATR)
- MODV 0.21
- COCP 0.18
- MACD
- MODV 0.06
- COCP 0.01
- Stochastic Oscillator
- MODV 29.41
- COCP 50.00
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).